Scleroderma-like illness as a presenting feature of multiple myeloma and amyloidosis

Journal of Clinical Rheumatology

Volumn 14, Issue 3, 2008, Pages 161-165

  Casim Reyes, Candice Marie ^a,c   Rudinskaya, Alla ^a   Kloss, Robert ^a   Girardi, Michael ^b   Lazova, Rossitza ^b  

^a DANBURY HOSPITAL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Unit A4   (United States)

Author keywords

Amyloidosis; Multiple myeloma; Scleroderma like

Indexed keywords

AMYLOID; ANTINUCLEAR ANTIBODY; BENCE JONES PROTEIN; C REACTIVE PROTEIN; CONGO RED; CRYSTAL VIOLET; DEXAMETHASONE; DOXORUBICIN; HYDROXYCHLOROQUINE; PLASMA PROTEIN; PREDNISONE; VINCRISTINE;

ADULT; AMYLOIDOSIS; ARTHRALGIA; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CARPAL TUNNEL SYNDROME; CASE REPORT; CELL INFILTRATION; COMPUTER ASSISTED TOMOGRAPHY; DERMATITIS; DRUG MEGADOSE; DYSPHAGIA; ECCHYMOSIS; ECHOCARDIOGRAPHY; ECHOGRAPHY; ERYTHEMA; ERYTHROCYTE SEDIMENTATION RATE; FACE; FEMALE; FLEXION CONTRACTURE; FLOW CYTOMETRY; FOOT; FOREARM; HAND; HOARSENESS; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOGLOBULIN DEFICIENCY; LEG SWELLING; LEUKOCYTOCLASTIC VASCULITIS; LUNG FUNCTION TEST; MACROGLOSSIA; METACARPOPHALANGEAL JOINT; MOUTH; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; MULTIPLE MYELOMA; PAIN; PHOTOSENSITIVITY; PLASMA CELL; PLASMACYTOSIS; POLYARTHRITIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN ELECTROPHORESIS; PROTEIN URINE LEVEL; PROTEINURIA; PROXIMAL INTERPHALANGEAL JOINT; RASH; RHEUMATOID ARTHRITIS; SCLERODERMA; SCLEROMYXEDEMA; SHOULDER; SKIN BIOPSY; SKIN BRUISING; SKIN FIBROSIS; SKIN SWELLING; SKIN TIGHTNESS; SKINFOLD; SYSTEMIC LUPUS ERYTHEMATOSUS; WELLS SYNDROME; WRIST; BONE MARROW EXAMINATION; CYTOCHEMISTRY; LOCALIZED SCLERODERMA; PATHOLOGY; URINE;

ADULT; AMYLOIDOSIS; BENCE JONES PROTEIN; BONE MARROW EXAMINATION; ERYTHEMA; FEMALE; HISTOCYTOCHEMISTRY; HUMANS; MULTIPLE MYELOMA; SCLERODERMA, LOCALIZED;

EID: 48249090893     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e3181775a15     Document Type: Article

References (20)

1. Casper C, Scharffetter-Kochanek K, Bohlen H, et al. Light chain multiple myeloma with peripheral leucocytosis presenting as scleroderma amyloido-sum of the AL type. Br J of Dermatol. 1999;140:1172-1174.
2. Bayer-Garner I, Smoller B. The spectrum of cutaneous disease in multiple myeloma. J Am Acad Dermatol. 2003;48:497-507.
3. Lowe WC. Scleroderma and amyloidosis. Mil Med. 1969;134:1430-1433.
4. Mistry C, Wagholikar U, Deshpande A, et al. Primary systemic amy-loidosis presenting as scleroderma: a case report. J Assoc Phys India. 1978;26:451-452.
5. Jablonska S, Stachow A. Scleroderma-like lesions in multiple myeloma. Dermatologica. 1972;144:257-269.
6. Sabadini L, Pipitone N, Marcolongo R. A case of amyloidosis due to multiple myeloma that resembled systemic sclerosis. J Rheumatol. 1997;24:1018.
7. Ogiyama Y. Cutaneous amyloidosis in patients with progressive systemic sclerosis. Cutis. 1996;57:28-32.
8. Black MM. Primary localised cutaneous amyloidosis in systemic sclerosis. Trans St Johns Hosp Dermatol Soc. 1971;57:177-180.
9. Azon-Masoliver A. Widespread primary localized cutaneous amyloid-osis (macular) form associated with systemic sclerosis. Br J Dermatol. 1995;132:163-165.
10. Chanoki M, Suzuki S, Hayashi Y, et al. Progressive systemic sclerosis associated with cutaneous amyloidosis. Int J Dermatol. 1994;33:648 - 649.
11. Bolster M, Maricq H, Leff R. Office evaluation and treatment of Raynaud's phenomenon. Cleve Clin J Med. 1995;62:51-61.
12. Cutolo M, Sulli A, Secchi M, et al. Nailfold capillaroscopy is useful for the diagnosis and follow-up of autoimmune rheumatic diseases. A future tool for the analysis of microvascular heart involvement? Rheumatology Oxf. 2006;45(suppl 4):iv43-iv46.
13. Tada S, Iida M, Iwashita A, et al. Endoscopic and biopsy findings of the upper digestive tract in patients with amyloidosis. Gastrointest Endosc. 1990;36:10.
14. Tada S, Iida M, Yao T, et al. Intestinal pseudo-obstruction in patients with amyloidosis: clinicopathologic differences between chemical types of amyloid protein. Gut. 1993;34:1412.
15. Kyle R, Gertz M. Primary systemic amyloidosis: clinical and laboratory features of 474 cases. Semin Hematol. 1995;32:45.
16. de Ruiter E, Ronday H, Markusse H. Amyloidosis mimicking rheumatoid arthritis. Clin Rheumatol. 1998;17:409.
17. Longo D, Anderson K. Plasma cell disorders. In: Kasper D, Braunwald E, Hauser S, et al, eds. Harrison's Principles of Internal Medicine. 16th ed. New York: McGraw-Hill; 2005:657-659.
18. Sipe J, Cohen A. Amyloidosis. In: Kasper D, Braunwald E, Hauser S, et al, eds. Harrison's Principles of Internal Medicine. 16th ed. New York: McGraw-Hill; 2005:2024.
19. Fautrel B, Fermand J, Sibilia J, et al. Amyloid arthropathy in the course of multiple myeloma. J Rheumatol. 2002;29:1473.
20. Sezer O, Eucker J, Jakob C, et al. Diagnosis and treatment of AL amyloidosis. Clin Nephrol. 2000;53:417.